Literature DB >> 29191838

Call for increased pharmacovigilance of gabapentin.

Alyssa M Peckham1, Kathleen A Fairman1, David A Sclar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29191838     DOI： 10.1136/bmj.j5456

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Authors' Reply to: Tomoyuki Kawada's Comment on: "All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population''.

Authors:  Alyssa M Peckham; Kathleen A Fairman; David A Sclar
Journal:  Drug Saf       Date:  2018-06       Impact factor: 5.606

2.  Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance.

Authors:  Alyssa M Peckham; Maria J Ananickal; David A Sclar
Journal:  Risk Manag Healthc Policy       Date:  2018-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.